MANAGEMENT OF ENDOCRINE DISEASE: Morbidity in polycystic ovary syndrome.
Polycystic ovary syndrome (PCOS) is the most prevalent endocrine condition in premenopausal women. The syndrome is characterized by hyperandrogenism, irregular menses and polycystic ovaries when other etiologies are excluded. Obesity, insulin resistance and low vitamin D levels are present in more than 50% patients with PCOS, these factors along with hyperandrogenism could have adverse effects on long-term health. Hyperinflammation and impaired epithelial function were reported to a larger extent in women with PCOS and could particularly be associated with hyperandrogenism, obesity and insulin resistance. Available data from register-based and data linkage studies support that metabolic-vascular and thyroid diseases, asthma, migraine, depression and cancer are diagnosed more frequently in PCOS, whereas fracture risk is decreased. Drug prescriptions are significantly more common in PCOS than controls within all diagnose categories including antibiotics. The causal relationship between PCOS and autoimmune disease represents an interesting new area of research. PCOS is a lifelong condition and long-term morbidity could be worsened by obesity, sedentary way of life, Western-style diet and smoking, whereas lifestyle intervention including weight loss may partly or fully resolve the symptoms of PCOS and could improve the long-term prognosis. In this review, the possible implications of increased morbidity for the clinical and biochemical evaluation of patients with PCOS at diagnosis and follow-up is further discussed along with possible modifying effects of medical treatment.
Department of EndocrinologyOdense University Hospital, Odense C, Denmark dorte.glintborg@rsyd.dk.
Dorte
D
Glintborg
Department of EndocrinologyOdense University Hospital, Odense C, Denmark.
Marianne
M
Andersen
D015519:Bone Density / Q000502:physiology; D003863:Depression / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D004700:Endocrine System Diseases / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D009369:Neoplasms / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000378:metabolism / Q000503:physiopathology